Multiple Sclerosis, Viruses, and New Vaccines

Neurol Int. 2021 Dec 13;13(4):712-714. doi: 10.3390/neurolint13040068.

Author

Peter A C Maple^{1

2}

Affiliations

¹ Nottingham Centre for Multiple Sclerosis and Neuroinflammation, Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
² Division of Clinical Neuroscience, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK.

Abstract

Multiple sclerosis (MS) is the most common inflammatory neurological disease in young adults, with an estimated prevalence of approximately 2 [...].

Publication types

Editorial